Primary Ciliary Dyskinesia in Adult Bronchiectasis

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT07566611
Status
Recruiting
Apply to this trial

Conditions

  • Idiopathic Bronchiectasis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Nasal Nitric Oxide Measurement — PROCEDURE
    Subjects will have their nasal nitric oxide measured using commercially available chemiluminescence analyzer in accordance with American Thoracic Society/European Respiratory Society guidelines
  • Nasopharyngeal (Nasal) Samples — PROCEDURE
    Human nasal epithelial cells will be collected via nasal swab, nasal curettage or nasal brush from each nostril.

Study Details

The purpose of this study is to help determine how often primary ciliary dyskinesia (PCD) is present but undiagnosed in adults with bronchiectasis.

Key Dates

First listed
May 5, 2026
Start date
Jul 17, 2026
Status verified
Aug 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Bronchiectasis
    patients with a known or new diagnosis of bronchiectasis

Primary Outcome Measure

Percentage of participants with a screen positive result [ Time Frame: From Baseline through study completion, approximately two years. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Riley Hospital for ChildrenIndianapolisIndiana46202
Kenzie Mahan
[email protected]
3172748899

Find similar trials in Indianapolis, IN

By research site
Riley Hospital for Children· Indianapolis, IN